389 related articles for article (PubMed ID: 21881129)
21. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
[TBL] [Abstract][Full Text] [Related]
22. Identification of a 67-amino-acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates.
Gamain B; Smith JD; Avril M; Baruch DI; Scherf A; Gysin J; Miller LH
Mol Microbiol; 2004 Jul; 53(2):445-55. PubMed ID: 15228526
[TBL] [Abstract][Full Text] [Related]
23. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.
Staalsoe T; Megnekou R; Fievét N; Ricke CH; Zornig HD; Leke R; Taylor DW; Deloron P; Hviid L
J Infect Dis; 2001 Sep; 184(5):618-26. PubMed ID: 11494167
[TBL] [Abstract][Full Text] [Related]
24. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
[TBL] [Abstract][Full Text] [Related]
25. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
[TBL] [Abstract][Full Text] [Related]
26. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
27. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration.
Dahlbäck M; Rask TS; Andersen PH; Nielsen MA; Ndam NT; Resende M; Turner L; Deloron P; Hviid L; Lund O; Pedersen AG; Theander TG; Salanti A
PLoS Pathog; 2006 Nov; 2(11):e124. PubMed ID: 17112315
[TBL] [Abstract][Full Text] [Related]
28. VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
Rovira-Vallbona E; Monteiro I; Bardají A; Serra-Casas E; Neafsey DE; Quelhas D; Valim C; Alonso P; Dobaño C; Ordi J; Menéndez C; Mayor A
PLoS One; 2013; 8(7):e69753. PubMed ID: 23936092
[TBL] [Abstract][Full Text] [Related]
29. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.
Avril M; Cartwright MM; Hathaway MJ; Smith JD
Malar J; 2011 Feb; 10():36. PubMed ID: 21314945
[TBL] [Abstract][Full Text] [Related]
30. Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes.
Barfod L; Nielsen MA; Turner L; Dahlbäck M; Jensen AT; Hviid L; Theander TG; Salanti A
Infect Immun; 2006 Jul; 74(7):4357-60. PubMed ID: 16790811
[TBL] [Abstract][Full Text] [Related]
31. Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies.
Avril M; Gamain B; Lépolard C; Viaud N; Scherf A; Gysin J
Microbes Infect; 2006; 8(14-15):2863-71. PubMed ID: 17095277
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
[TBL] [Abstract][Full Text] [Related]
33. Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.
Gnidehou S; Mitran CJ; Arango E; Banman S; Mena A; Medawar E; Lima BAS; Doritchamou J; Rajwani J; Jin A; Gavina K; Ntumngia F; Duffy P; Narum D; Ndam NT; Nielsen MA; Salanti A; Kano FS; Carvalho LH; Adams JH; Maestre A; Good MF; Yanow SK
J Infect Dis; 2019 Jan; 219(1):110-120. PubMed ID: 30534974
[TBL] [Abstract][Full Text] [Related]
34. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
[TBL] [Abstract][Full Text] [Related]
35. Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum.
Mayor A; Kumar U; Bardají A; Gupta P; Jiménez A; Hamad A; Sigaúque B; Singh B; Quintó L; Kumar S; Gupta PK; Chauhan VS; Dobaño C; Alonso PL; Menéndez C; Chitnis CE
J Infect Dis; 2013 Jun; 207(11):1664-74. PubMed ID: 23448726
[TBL] [Abstract][Full Text] [Related]
36. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
[TBL] [Abstract][Full Text] [Related]
37. Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates.
Tuikue Ndam NG; Fievet N; Bertin G; Cottrell G; Gaye A; Deloron P
J Infect Dis; 2004 Dec; 190(11):2001-9. PubMed ID: 15529266
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
[TBL] [Abstract][Full Text] [Related]
40. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
